Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?

被引:124
|
作者
Zimetbaum, Peter J. [1 ]
Thosani, Amit
Yu, Hsing-Ting [2 ]
Xiong, Yan [2 ]
Lin, Jay [3 ]
Kothawala, Prajesh [2 ]
Emons, Matthew [2 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
[2] Cerner LifeSci, Beverly Hills, CA USA
[3] Sanofi Aventis, Bridgewater, NJ USA
来源
AMERICAN JOURNAL OF MEDICINE | 2010年 / 123卷 / 05期
关键词
Anticoagulation; Atrial fibrillation; Atrial flutter; Stroke risk; Warfarin; RHYTHM-CONTROL; ORAL ANTICOAGULATION; MANAGEMENT; THERAPY; PREVENTION; GUIDELINES; IMPACT;
D O I
10.1016/j.amjmed.2009.11.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Clinical guidelines for the management of atrial fibrillation and atrial flutter provide recommendations for anticoagulation based on patients' overall risk of stroke. To determine the real-world compliance of physicians with these recommendations, we conducted a retrospective cohort study examining the utilization of warfarin in atrial fibrillation/flutter patients by stroke risk level. METHODS: Patients with a qualifying atrial fibrillation/flutter diagnosis during >= 18 months' continuous enrollment between January 2003 and September 2007, and with >= 6 months' eligibility after the first atrial fibrillation/flutter diagnosis, were identified from the US Market Scan database (Thomson Reuters, New York, NY). Warfarin use within 30 days of the first diagnosis was assessed according to stroke risk, estimated using the Congestive heart failure, Hypertension, Age >75 years, Diabetes, Stroke (CHADS(2)) score. RESULTS: Of 171,393 patients included in the analysis, 20.0% had a CHADS(2) score of 0 (low risk), 61.6% a score of 1-2 (moderate risk), and 18.4% a score of 3-6 (high risk). Warfarin, recommended for high stroke-risk patients, was given to only 42.1% of those with a CHADS(2) score of 3-6. A similar percentage of patients with moderate (43.5%) or low stroke risk (40.1%) received warfarin. Only 29.6% of high-risk, 33.3% of moderate-risk, and 34.1% of low-risk patients who were started on warfarin received. uninterrupted therapy for 6 months following their initial prescription. CONCLUSIONS: These data suggest that guideline recommendations that anticoagulation should be provided in accordance with stroke risk in atrial fibrillation patients are not routinely followed in clinical practice. The causes and clinical implications of under-utilization of anticoagulation in atrial fibrillation patients with high stroke risk warrant further study. (c) 2010 Elsevier Inc. All rights reserved. The American Journal of Medicine (2010) 123, 446-453
引用
收藏
页码:446 / 453
页数:8
相关论文
共 50 条
  • [1] Risk factor profile for ischaemic stroke in atrial fibrillation patients not receiving warfarin
    Wensley, S
    Keir, SL
    Caine, S
    Mac Mahon, M
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (09) : S44 - S44
  • [2] Additional risk factors in atrial fibrillation patients not receiving warfarin
    Gupta, A
    Thomas, P
    [J]. AGE AND AGEING, 2000, 29 (02) : 185 - 186
  • [3] Additional risk factors in atrial fibrillation patients not receiving warfarin
    Wensley, S
    Keir, S
    Caine, S
    Mac Mahon, M
    [J]. AGE AND AGEING, 1999, 28 (04) : 355 - 357
  • [4] Warfarin increases stroke risk in atrial fibrillation
    Tofield, Andros
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (22) : 1421 - 1421
  • [5] Risk of Stroke Outcomes in Atrial Fibrillation Patients Treated with Rivaroxaban and Warfarin
    Milentijevic, Dejan
    Lin, Jennifer H.
    Connolly, Nancy
    Chen, Yen-Wen
    Kogan, Emily
    Shrivastava, Shubham
    Sjoeland, Erik
    Alberts, Mark J.
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (05):
  • [6] WARFARIN AND THE RISK OF STROKE AND BLEEDING IN ATRIAL FIBRILLATION PATIENTS UNDERGOING DIALYSIS
    Tsadok, Meytal Avgil
    Jackevicius, Cynthia
    Eisenberg, Mark
    Shah, Mitesh
    Essebag, Vidal
    Rahme, Elham
    Humphries, Karin
    Tu, Jack
    Pilote, Louise
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E340 - E340
  • [7] Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis
    Harel, Ziv
    Chertow, Glenn M.
    Shah, Prakesh S.
    Harel, Shai
    Dorian, Paul
    Yan, Andrew T.
    Saposnik, Gustavo
    Sood, Manish M.
    Molnar, Amber O.
    Perl, Jeffrey
    Wald, Rachel M.
    Silver, Sam
    Wald, Ron
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2017, 33 (06) : 737 - 746
  • [8] Relation of Race, Apparent Disability, and Stroke Risk With Warfarin Prescribing for Atrial Fibrillation in Patients Receiving Maintenance Hemodialysis
    Wetmore, James B.
    Peng, Yi
    Gilbertson, David T.
    Liu, Jiannong
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (04): : 598 - 604
  • [9] Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis
    Qureshi, Waqas
    Alirhayim, Zaid
    Khalid, Fatima
    [J]. CIRCULATION, 2014, 130 (25) : E427 - E427
  • [10] Warfarin treatment and risk of stroke among primary care patients with atrial fibrillation
    Wandell, Per
    Carlsson, Axel C.
    Holzmann, Martin J.
    Arnlov, Johan
    Johansson, Sven-Erik
    Sundquist, Jan
    Sundquist, Kristina
    [J]. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2016, 50 (5-6) : 311 - 316